To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.

• Status: Completed
• Trial end date: 2005-11-01
• Target enrollment: 0
• Participant gender: All

Summary

To evaluate long-term safety and efficacy of pregabalin in patients with partial seizures.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pfizer
• Treatments: Pregabalin

Criteria

Inclusion Criteria:

• Must have met the inclusion criteria for preceding double-blind study

• Have received double-blind study medication and wish to receive open-label pregabalin.

Exclusion Criteria:

• Cannot have absence seizures